Unlike KC2, KC3 tumours exhibited downregulation of cell cycle‐associated pathways, including mitotic spindle, E2F targets, G2/M checkpoint, MYC targets, mTORC1 signalling and hypoxia‐related pathways (Figure S5A and Tables S2 and S4). This evidence concerns the gene MYC and neoplasm.